Effect of everolimus on the pharmacokinetics of octreotide long-acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT-2 trial

  • ME Pavel, C Becerra, K Grosch, W Cheung, J Hasskarl, JC Yao
  • Clinical Pharmacology & Therapeutics, December 2016, Wiley
  • DOI: 10.1002/cpt.559

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/cpt.559

In partnership with: